Parker Institute for Cancer Immunotherapy

The Latest at the Parker Institute

PICI JDRF Helmsley Diabetes Cancer ResearchInitiative WHATSNEW Featured

Press Releases

Parker Institute for Cancer Immunotherapy, JDRF and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative

May 29, 2019

Meet the Team

Smarter, Bolder Cancer Immunotherapy Clinical Trials

May 23, 2019

Clinical Trials, Press Releases

For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

March 31, 2019

More

The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.

World-renowned experts from leading cancer centers are at the forefront of our research.

About Our Model

Open in Twitter

Parker Institute @parkerici 🐶🐾 Dogs and humans share more in common than you might think. Scientists are using promising #immunotherapy approac… https://t.co/OqSn9oXhOy 2 days ago

Open in Twitter

Parker Institute @parkerici Can a blood test predict if people with breast cancer will relapse? @cityofhope researchers developed one used at t… https://t.co/lQ0b2GN2tI 3 days ago

Open in Twitter

Parker Institute @parkerici PICI researcher Anusha Kalbasi at @UCLAJCCC, treats #sarcomas in the clinic. In the lab, he’s working on designing… https://t.co/5bb0DAoje5 4 days ago

Follow @parkerici

Hacking Cancer Together

We dream big. We imagine a world where cancer is curable.

The Latest at the Parker Institute